ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE PATIENTS.
Conference
25th UEG Week 2017
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing